Bader B - Search Results

1

KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.

Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A. Burkhardt M, et al. Among authors: bader b. J Biol Chem. 2000 Oct 27;275(43):33536-41. doi: 10.1074/jbc.M005670200. J Biol Chem. 2000. PMID: 10922374 Free article.

2

A cGMP-dependent protein kinase assay for high throughput screening based on time-resolved fluorescence resonance energy transfer.

Bader B, Butt E, Palmetshofer A, Walter U, Jarchau T, Drueckes P. Bader B, et al. J Biomol Screen. 2001 Aug;6(4):255-64. doi: 10.1177/108705710100600407. J Biomol Screen. 2001. PMID: 11689125

3

Blood pressure reduction is necessary for the reduction of proteinuria in diabetic nephropathy--comparison of different antihypertensive agents.

Berger ED, Setzler BA, Werz U, Bader BD, Lipp HP, Risler T, Erley CM. Berger ED, et al. Among authors: bader bd. Nephrol Dial Transplant. 1999;14 Suppl 4:28-9. doi: 10.1093/ndt/14.suppl_4.28. Nephrol Dial Transplant. 1999. PMID: 10463204 Clinical Trial. No abstract available.

4

Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition.

Berger ED, Bader BD, Ebert C, Risler T, Erley CM. Berger ED, et al. J Hypertens. 2002 Apr;20(4):739-43. doi: 10.1097/00004872-200204000-00033. J Hypertens. 2002. PMID: 11910311 Clinical Trial.

5

Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.

Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S. Erley CM, et al. Nephrol Dial Transplant. 2004 Oct;19(10):2526-31. doi: 10.1093/ndt/gfh272. Epub 2004 Jul 27. Nephrol Dial Transplant. 2004. PMID: 15280530 Clinical Trial.

6

Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.

Berger ED, Bader BD, Rüb N, Rauscher MA, Rebenschütz I, Gaber OC, Enderle MD, Risler T, Erley CM. Berger ED, et al. Kidney Blood Press Res. 2002;25(1):42-9. doi: 10.1159/000049434. Kidney Blood Press Res. 2002. PMID: 11834876 Clinical Trial.

7

[Contrast media-induced kidney failure cannot be prevented by hemodialysis].

Berger ED, Bader BD, Bösker J, Risler T, Erley CM. Berger ED, et al. Among authors: bader bd. Dtsch Med Wochenschr. 2001 Feb 16;126(7):162-6. doi: 10.1055/s-2001-11198. Dtsch Med Wochenschr. 2001. PMID: 11236522 Clinical Trial. German.

8

What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?

Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T, Erley CM. Bader BD, et al. Clin Nephrol. 2004 Jul;62(1):1-7. doi: 10.5414/cnp62001. Clin Nephrol. 2004. PMID: 15267006 Clinical Trial.

9

[Consequences of intravascular contrast media on kidney function-- risk and prevention].

Erley CM, Bader BD. Erley CM, et al. Among authors: bader bd. Rofo. 2000 Oct;172(10):791-7. doi: 10.1055/s-2000-7889. Rofo. 2000. PMID: 11111289 Review. German.

10

Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients.

Erley CM, Bader BD, Berger ED, Vochazer A, Jorzik JJ, Dietz K, Risler T. Erley CM, et al. Among authors: bader bd. Crit Care Med. 2001 Aug;29(8):1544-50. doi: 10.1097/00003246-200108000-00008. Crit Care Med. 2001. PMID: 11505124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters